| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/29/2013 | US20130225561 Inhibitors of the renal outer medullary potassium channel |
| 08/29/2013 | US20130225548 Pyridine Derivative and Medicinal Agent |
| 08/29/2013 | US20130224299 Novel Process For The Preparation Of Roflumilast |
| 08/28/2013 | EP2630123A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 08/28/2013 | EP2630122A1 Arylamide derivatives as ttx-s blockers |
| 08/28/2013 | CN103270023A 4- { [ ( pyridin- 3 - Yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer |
| 08/28/2013 | CN103265479A Synthetic method of 6-chloromethyl niacin tert-butyl ester |
| 08/28/2013 | CN103265478A Mercaptonicotinic acid compounds and preparation method thereof |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN102190625B Stilbene tumor targeted medicine Combretastatin A4 analogs |
| 08/28/2013 | CN102180911B Nitrogen-oxygen ligand with planar chirality and central chirality and metal complex thereof |
| 08/28/2013 | CN102093320B Soluble epoxide hydrolase inhibitor |
| 08/28/2013 | CN101986781B Crystalline I-(3-fluorophenyl)-5-methyl-2-(1H)pyridone, the preparation methods, compositions and applications thereof |
| 08/28/2013 | CN101948424B Preparation method for 2-chloro-5-chloromethyl pyridine |
| 08/28/2013 | CN101835745B Process for production of disulfonic acid compound, asymmetric mannich catalyst, process for production of beta-aminocarbonyl derivative, and novel disulfonate salt |
| 08/28/2013 | CN101787016B Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 08/27/2013 | US8519145 Aryl compounds as PPAR ligands and their use |
| 08/27/2013 | US8519144 Process for the preparation of aryl-piridyl compounds |
| 08/27/2013 | US8519142 Aryl pyridine as aldosterone synthase inhibitors |
| 08/27/2013 | US8519141 Biological buffers with wide buffering ranges |
| 08/27/2013 | US8519130 Method for synthesis of iriduim (III) complexes with sterically demanding ligands |
| 08/27/2013 | US8518977 Benzamides and related inhibitors of factor XA |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518948 Inhibitors of protein kinases |
| 08/27/2013 | CA2754998C Substituted nicotinamides as kcnq2/3 modulators |
| 08/27/2013 | CA2580760C Aminoalcohol derivatives |
| 08/27/2013 | CA2531868C Process for the preparation of thalidomide |
| 08/22/2013 | WO2013123444A1 Sulfonyl compounds that interact with glucokinase regulatory protein |
| 08/22/2013 | WO2013123349A1 Methods of producing sulfilimine compounds |
| 08/22/2013 | WO2013062966A3 Methanol derivatives as trpv3 modulators |
| 08/22/2013 | US20130217883 Methods of producing sulfilimine compounds |
| 08/22/2013 | US20130217876 Phosphine ligands for catalytic reactions |
| 08/22/2013 | US20130217714 Non-Flushing Niacin Analogues, and Methods of Use Thereof |
| 08/22/2013 | US20130217706 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 08/22/2013 | US20130217698 Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof |
| 08/22/2013 | US20130217692 Cyclic amide derivative |
| 08/22/2013 | US20130217687 Arylsulfonamide ccr3 antagonists |
| 08/22/2013 | US20130217686 Novel methylcyclohexane derivatives and uses thereof |
| 08/22/2013 | US20130217660 Novel prolylcarboxypeptidase inhibitors |
| 08/21/2013 | EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders |
| 08/21/2013 | EP2627637A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides |
| 08/21/2013 | EP2627636A1 Process for making bortezomib and intermediates for the process |
| 08/21/2013 | EP2627329A1 Trpa1 receptor antagonist |
| 08/21/2013 | EP2627324A2 Substituted benzamides and their uses |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261169A Deubiquitinase inhibitors and methods for use of the same |
| 08/21/2013 | CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators |
| 08/21/2013 | CN103261164A Neprilysin inhibitors |
| 08/21/2013 | CN103261163A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)- pyridin-3-yl]- carbamic acid ethyl ester and an arylpropionic acid |
| 08/21/2013 | CN103261162A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid |
| 08/21/2013 | CN103261161A Crystalline forms of a factor Xa inhibitor |
| 08/21/2013 | CN103261160A Guanidine compounds and compositions for the inhibition of nampt |
| 08/21/2013 | CN103254250A Ferrocenyl pyridine cyclic Pd-N heterocyclic carbene compound as well as preparation method and application thereof |
| 08/21/2013 | CN103254127A Glycine-reuptake inhibitor and application thereof |
| 08/21/2013 | CN103254126A Deuterated omega-diphenyl carbamide as well as derivative and pharmaceutical composition including compounds |
| 08/21/2013 | CN103254125A Pest control agent |
| 08/21/2013 | CN103254124A N-[4-chloro-3-(pyridinyl-2-radical)phenyl]-2-chloro-4(methylsulfonyl)-benzamide derivative and application thereof |
| 08/21/2013 | CN103254123A Method for synthesizing paraquat through cyanamide process |
| 08/21/2013 | CN103254065A 2,3,4',6-tetracarboxylic acid biphenyl silver complex and preparation method and application thereof |
| 08/21/2013 | CN103254053A Alpha-fluoro-chalcone type compound and preparation and application thereof |
| 08/21/2013 | CN103252254A Catalyst for synthesizing 2-methyl pyridine and 4-methyl pyridine and preparation method of catalyst |
| 08/21/2013 | CN103252233A Hydrolysis catalyst and preparation method thereof, and method for preparing nicotinamide by utilizing hydrolysis catalyst |
| 08/21/2013 | CN102702088B Method for preparing 3,5,6-trichloropyridine-2-ol sodium |
| 08/21/2013 | CN102311383B Phenazopyridine hydrochloride crystal compound and pharmaceutical composition tablet thereof |
| 08/21/2013 | CN102127056B Tubulin inhibitors |
| 08/21/2013 | CN102099337B Piperazine derivatives used as cav2.2 calcium channel modulators |
| 08/21/2013 | CN102046599B Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
| 08/21/2013 | CN101790517B Inhibitor of binding of s1p1 |
| 08/21/2013 | CN101723976B Ionic liquids comprising fluoralkyltriffluoroborate anions |
| 08/21/2013 | CN101712867B Organic electronic transmission and/or hole barrier materials, synthetic method and applications thereof |
| 08/21/2013 | CN101495453B Process for the manufacture of HI-6 dimethanesulfonate |
| 08/21/2013 | CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 08/20/2013 | US8513428 Process for preparing atazanavir bisulfate and novel forms |
| 08/20/2013 | US8513286 Iminipyridine derivatives and their uses as microbiocides |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/20/2013 | US8512534 Redox polymers |
| 08/20/2013 | CA2751495C Pharmaceutical compositions comprising a pyridyl cyanoguanidine and cyclodextrin and/or derivatives thereof |
| 08/20/2013 | CA2723302C Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 08/20/2013 | CA2717069C Pesticides |
| 08/20/2013 | CA2606262C Novel histamine h3-receptor ligands and their therapeutic applications |
| 08/20/2013 | CA2602445C Metabolites for nk-i antagonists for emesis |
| 08/20/2013 | CA2589497C Novel specific caspase-10 inhibitors |
| 08/15/2013 | WO2013119928A1 Process for the preparation of 1-hydroxy-6-substituted pyridones |
| 08/15/2013 | WO2013117701A1 Voltage-switchable nanoparticle-dye complex |
| 08/15/2013 | WO2013062964A3 Methanol derivatives as trpv3 modulators |
| 08/15/2013 | US20130211094 METHODS OF SYNTHESIZING FACTOR Xa INHIBITORS |
| 08/15/2013 | US20130211093 Process for the Preparation of 1-Hydroxy-6-Substituted Pyridones |
| 08/15/2013 | US20130211085 Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives |
| 08/15/2013 | US20130211045 Macrocyclic modulators of the ghrelin receptor |
| 08/15/2013 | US20130210865 Sorafenib dimethyl sulphoxide solvate |
| 08/15/2013 | US20130210822 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/15/2013 | US20130210814 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 08/15/2013 | US20130210800 Pyridine-2-derivatives as smoothened receptor modulators |
| 08/15/2013 | US20130210798 Soluble guanylate cyclase activators |
| 08/15/2013 | US20130210795 Substituted dicyanopyridines and use thereof |
| 08/15/2013 | US20130210793 Photolabile caged transition metal complexes and methods of using the same |
| 08/15/2013 | US20130210158 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 08/15/2013 | US20130209483 Cannabidinoid derivatives |
| 08/14/2013 | EP2626348A1 Heterocyclic amides as rock inhibitors |
| 08/14/2013 | EP2626347A1 Dalfampridine polymorph, preparation therefor, and application thereof |